Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1988 Mar;26(3):552–556. doi: 10.1128/jcm.26.3.552-556.1988

Comparison of six serological assays for human immunodeficiency virus antibody detection in developing countries.

P Van de Perre 1, D Nzaramba 1, S Allen 1, C H Riggin 1, S Sprecher-Goldberger 1, J P Butzler 1
PMCID: PMC266330  PMID: 3281979

Abstract

Three commercially available assays for the detection of human immunodeficiency virus (HIV) antibodies-Vironostika enzyme immunoassay (EIA), Wellcozyme competitive EIA, and JLC Allaman indirect immunofluorescence assay--were tested on 300 serum samples from African subjects with and without HIV-related conditions. Two experimental assays both rapid and simple to perform (Biotech dip stick and Cambridge Bioscience latex agglutination) were also evaluated on the same serum samples. The results were compared with those of a commercial Western blot (WB) (immunoblot) assay from Biotech, used as the reference technique. All assays were tested in the laboratory of the AIDS Project in Kigali, Rwanda. Calculated specificity ranged from 90.8% (dip stick) to 98.6% (Vironostika EIA, Wellcozyme competitive EIA, and Cambridge Bioscience latex agglutination). Sensitivity ranged from 95.2% (Cambridge Bioscience latex agglutination) to 98.0% (Vironstika EIA) and JLC indirect immunofluorescence assay). However, the sensitivity of the latex agglutination test improved to 98.6% after the prozone effect was controlled for by serial twofold dilution of latex agglutination-negative, WB-positive samples. In situations with a high prevalence of HIV infection, any one of these tests can be regarded as an alternative to the more expensive, time-consuming, and difficult WB assay.

Full text

PDF
552

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barin F., M'Boup S., Denis F., Kanki P., Allan J. S., Lee T. H., Essex M. Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet. 1985 Dec 21;2(8469-70):1387–1389. doi: 10.1016/s0140-6736(85)92556-5. [DOI] [PubMed] [Google Scholar]
  2. Biberfeld G., Bredberg-Rådén U., Böttiger B., Putkonen P. O., Blomberg J., Juto P., Wadell G. Blood donor sera with false-positive Western blot reactions to human immunodeficiency virus. Lancet. 1986 Aug 2;2(8501):289–290. doi: 10.1016/s0140-6736(86)92111-2. [DOI] [PubMed] [Google Scholar]
  3. Biggar R. J., Gigase P. L., Melbye M., Kestens L., Sarin P. S., Bodner A. J., Demedts P., Stevens W. J., Paluku L., Delacollette C. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet. 1985 Sep 7;2(8454):520–523. doi: 10.1016/s0140-6736(85)90461-1. [DOI] [PubMed] [Google Scholar]
  4. Burke D. S., Redfield R. R. False-positive Western blot tests for antibodies to HTLV-III. JAMA. 1986 Jul 18;256(3):347–347. [PubMed] [Google Scholar]
  5. Carlson J. R., Mertens S. C., Yee J. L., Gardner M. B., Watson-Williams E. J., Ghrayeb J., Jennings M. B., Biggar R. J. Rapid, easy, and economical screening test for antibodies to human immunodeficiency virus. Lancet. 1987 Feb 14;1(8529):361–362. doi: 10.1016/s0140-6736(87)91730-2. [DOI] [PubMed] [Google Scholar]
  6. Carswell J. W., Sewankambo N., Lloyd G., Downing R. G. How long has the AIDS virus been in Uganda? Lancet. 1986 May 24;1(8491):1217–1217. doi: 10.1016/s0140-6736(86)91201-8. [DOI] [PubMed] [Google Scholar]
  7. Colebunders R., Mann J. M., Francis H., Bila K., Izaley L., Kakonde N., Kabasele K., Ifoto L., Nzilambi N., Quinn T. C. Evaluation of a clinical case-definition of acquired immunodeficiency syndrome in Africa. Lancet. 1987 Feb 28;1(8531):492–494. doi: 10.1016/s0140-6736(87)92099-x. [DOI] [PubMed] [Google Scholar]
  8. Couroucé A. M., Muller J. Y., Richard D. False-positive Western blot reactions to human immunodeficiency virus in blood donors. Lancet. 1986 Oct 18;2(8512):921–922. doi: 10.1016/s0140-6736(86)90443-5. [DOI] [PubMed] [Google Scholar]
  9. Denis F., Barin F., Gershy-Damet G., Rey J. L., Lhuillier M., Mounier M., Leonard G., Sangare A., Goudeau A., M'Boup S. Prevalence of human T-lymphotropic retroviruses type III (HIV) and type IV in Ivory Coast. Lancet. 1987 Feb 21;1(8530):408–411. doi: 10.1016/s0140-6736(87)90118-8. [DOI] [PubMed] [Google Scholar]
  10. Denis F., Leonard G., Mounier M., Sangare A., Gershy-Damet G., Rey J. L. Efficacy of five enzyme immunoassays for antibody to HIV in detecting antibody to HTLV-IV. Lancet. 1987 Feb 7;1(8528):324–325. doi: 10.1016/s0140-6736(87)92046-0. [DOI] [PubMed] [Google Scholar]
  11. Lepage P., Van de Perre P., Caraël M., Butzler J. P. Are medical injections a risk factor for HIV infection in children? Lancet. 1986 Nov 8;2(8515):1103–1104. doi: 10.1016/s0140-6736(86)90508-8. [DOI] [PubMed] [Google Scholar]
  12. Mann J. M., Francis H., Davachi F., Baudoux P., Quinn T. C., Nzilambi N., Bosenge N., Colebunders R. L., Piot P., Kabote N. Risk factors for human immunodeficiency virus seropositivity among children 1-24 months old in Kinshasa, Zaire. Lancet. 1986 Sep 20;2(8508):654–657. doi: 10.1016/s0140-6736(86)90167-4. [DOI] [PubMed] [Google Scholar]
  13. Mann J. M., Francis H., Mwandagalirwa K., Ndongala L., Mavunza-Paka D., Baekert G., Malonga M., Bosenge N., Nzilambi N., Colebunders R. C. ELISA readers and HIV antibody testing in developing countries. Lancet. 1986 Jun 28;1(8496):1504–1504. doi: 10.1016/s0140-6736(86)91541-2. [DOI] [PubMed] [Google Scholar]
  14. Melbye M., Njelesani E. K., Bayley A., Mukelabai K., Manuwele J. K., Bowa F. J., Clayden S. A., Levin A., Blattner W. A., Weiss R. A. Evidence for heterosexual transmission and clinical manifestations of human immunodeficiency virus infection and related conditions in Lusaka, Zambia. Lancet. 1986 Nov 15;2(8516):1113–1115. doi: 10.1016/s0140-6736(86)90527-1. [DOI] [PubMed] [Google Scholar]
  15. Rey F., Salaun D., Lesbordes J. L., Gadelle S., Ollivier-Henry F., Barré-Sinoussi F., Chermann J. C., Georges A. J. HIV-I and HIV-II double infection in Central African Republic. Lancet. 1986 Dec 13;2(8520):1391–1392. doi: 10.1016/s0140-6736(86)92027-1. [DOI] [PubMed] [Google Scholar]
  16. Riggin C. H., Beltz G. A., Hung C. H., Thorn R. M., Marciani D. J. Detection of antibodies to human immunodeficiency virus by latex agglutination with recombinant antigen. J Clin Microbiol. 1987 Sep;25(9):1772–1773. doi: 10.1128/jcm.25.9.1772-1773.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sandstrom E. G., Schooley R. T., Ho D. D., Byington R., Sarngadharan M. G., MacLane M. E., Essex M., Gallo R. C., Hirsch M. S. Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells. Transfusion. 1985 Jul-Aug;25(4):308–312. doi: 10.1046/j.1537-2995.1985.25485273806.x. [DOI] [PubMed] [Google Scholar]
  18. Sarngadharan M. G., Popovic M., Bruch L., Schüpbach J., Gallo R. C. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science. 1984 May 4;224(4648):506–508. doi: 10.1126/science.6324345. [DOI] [PubMed] [Google Scholar]
  19. Van de Perre P., Clumeck N., Carael M., Nzabihimana E., Robert-Guroff M., De Mol P., Freyens P., Butzler J. P., Gallo R. C., Kanyamupira J. B. Female prostitutes: a risk group for infection with human T-cell lymphotropic virus type III. Lancet. 1985 Sep 7;2(8454):524–527. doi: 10.1016/s0140-6736(85)90462-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES